Pablo Engel Rocamora;Enric Esplugues Artola;David Sancho Madrid;Pilar Lauzurica Gomez;Carlos-Martinez Alonso;Javier Vega Ramos;Francisco Sanchez-Madrid
发明人:
Francisco Sanchez-Madrid,Carlos-Martinez Alonso,David Sancho Madrid,Pablo Engel Rocamora,Enric Esplugues Artola,Javier Vega Ramos,Pilar Lauzurica Gomez
申请号：
US12944338
公开号：
US08182816B2
申请日:
2010.11.11
申请国别(地区):
US
年份:
2012
代理人:
摘要：
Disclosed are methods of treating subjects having cancers including administering an effective amount of an early activation molecule agonist, antagonist or depletor, to the subject. Human monoclonal antibodies specific to the early activation molecules, and methods of use, are also disclosed.
